PMID: 8584756Oct 20, 1995Paper

ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release

Regulatory Peptides
M G HulseyR J Martin

Abstract

Neuropeptide-Y (NPY) is a potent stimulator of feeding, and chronic administration of the peptide has been shown to increase body weight. This study determined the chronic effects of repeated daily injections of an antisense phosphorothioate oligonucleotide complementary to the rat mRNA for NPY (aNPY) on food intake, feeding behavior and body weight change in rats. Five micrograms of the aNPY oligonucleotide in ten microliters of vehicle or a missense control oligonucleotide were administered intracerebroventricularly (ICV) for seven consecutive days. Cumulative food intake, meal size and meal duration were significantly lowered in aNPY-treated animals. Body weight change of aNPY-injected animals was significantly lower than controls, and the effect was reversed after treatments ceased. A two-bottle taste aversion paradigm was employed to determine the behavioral specificity of the anorectic effect, and the phosphorothioate oligonucleotide was found not to be aversive at the dosage used. Following an additional five day injection period, animals were killed and paraventricular nuclei (PVN) were dissected. In vitro release and tissue content of NPY from this brain area were evaluated by heterologous radioimmunoassay. Content of ...Continue Reading

References

Dec 1, 1992·Physiology & Behavior·M G Hulsey, R J Martin
Jan 1, 1992·Critical Reviews in Biochemistry and Molecular Biology·M Kozak
Aug 1, 1991·Physiology & Behavior·M G Hulsey, R J Martin
Nov 1, 1991·Pharmacology & Therapeutics·J S Cohen
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J A JaegerM Zuker
Jul 1, 1989·Journal of Neurology·H ShojiT Okudera
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·L A YakubovV V Vlassov
Feb 1, 1989·The Journal of Cell Biology·M Kozak
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S L LokeL M Neckers
May 1, 1994·The Histochemical Journal·J Van Minnen

❮ Previous
Next ❯

Citations

Jan 16, 2002·Physiology & Behavior·C Broberger, T Hökfelt
Apr 24, 2001·Pharmacology & Therapeutics·J C ClaphamM Tadayyon
Nov 5, 1998·Regulatory Peptides·W T ChanceA Balasubramaniam
Nov 5, 1998·Regulatory Peptides·A O SchaffhauserA Stricker-Krongrad
Sep 1, 1997·Neurochemistry International·B WeissS P Zhang
Aug 1, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·B Beck
Jan 15, 2011·Journal of Nutrition and Metabolism·Soundararajan KamalakkannanMohammad A Akbarsha
Dec 17, 1998·The Journal of Clinical Investigation·L CriscioneN Levens
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Linda Ste MarieRichard D Palmiter
Feb 8, 2011·European Journal of Pharmacology·Rahul PanditRoger A H Adan
Jan 27, 2007·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Amy S Kehoe, Hélène Volkoff
Aug 20, 2003·The European Journal of Neuroscience·Ramla BenmaamarAntoine Depaulis
Nov 4, 2000·Expert Opinion on Investigational Drugs·H A WielandH N Doods
Mar 16, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S ChamorroN Levens
Apr 7, 1999·Antisense & Nucleic Acid Drug Development·A W Szklarczyk, L Kaczmarek
Aug 17, 2005·The European Journal of Neuroscience·Yih-Shou HsiehDong-Yih Kuo
Mar 13, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·O Della ZuanaN Levens
Feb 6, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·O Della-ZuanaN Levens
Nov 13, 2014·Hormone Molecular Biology and Clinical Investigation·Lori Asarian, Thomas Bächler
Apr 13, 2000·Cancer Control : Journal of the Moffitt Cancer Center·H H Engelhard
Mar 11, 2003·Experimental Biology and Medicine·Magnus M BerglundDonald R Gehlert
Feb 5, 2000·Neuropeptides·D R Gehlert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.